Drug-Induced Cancer & Infertility
The International Agency for Research on Cancer (IARC), a division of the World Health Organization (WHO), has classified combined oral contraceptives and hormone replacement therapy (HRT) as Group 1 carcinogens—meaning there is sufficient evidence that they cause cancer in humans. Studies have shown that prolonged use of these synthetic hormones increases the risk of breast, liver, and uterine cancer. According to a comprehensive review by the IARC, women who use combined oral contraceptives have a significantly higher risk of developing breast and cervical cancer, while HRT has been linked to an increased incidence of endometrial and liver cancers (IARC Monographs, 2007).
A large-scale study published in The Lancet Oncology further confirmed these findings, showing that current and recent users of oral contraceptives had an elevated risk of breast cancer, with the risk increasing the longer the drugs were used (Collaborative Group on Hormonal Factors in Breast Cancer, 2019). Additionally, research from the Journal of the National Cancer Institute highlights the strong correlation between synthetic estrogen-progestin combinations and hepatocellular carcinoma, the most common form of liver cancer (Bosetti et al., 2002). Despite this well-documented evidence, these drugs continue to be widely prescribed, often without sufficient warning about their carcinogenic potential.
It’s unfortunate how many conventional medical doctors fail to educate their patients on this potential side effect. Are they ignorant about this information or complicit in creating more cancer cases? Which is it?

Birth control and hormone replacement therapies are known to increase hs-CRP, homocysteine, fibrinogen (1,2,3). Are you testing patient levels with bloodwork? If not, they could be at risk of having a cardiovascular event.
When hs-CRP, homocysteine, fibrinogen are elevated, it could be signalling that the synthetic hormone therapy hasn’t fully cleared out of the body and the risk for strokes, especially by high estrogen intake (4). Furthermore, Deep vein thrombosis (DVT) has been reported as an adverse event for patients receiving combined oral contraceptive (5)
If you know of a person who is thinking about taking synthetic hormone therapy of some sort, they MUST read this book The Pill: Are you sure it’s for you?, by Jane Bennett and Alexandra Pope. It explores the physical and psychological repercussions of taking the pill – from side effects, like weight gain and depression to cancer, to effective alternative methods of contraception.
Female patients are at risk of developing symptoms related to drug-induced estrogen dominance, including drug-induced breast cancer, from exogenous female hormone therapy. Learn how to test hs-CRP, homocysteine, fibrinogen and more. Then learn nutritional solutions to support healthy levels.
Hear Lorey’s success story:
After years of endometriosis and since birth control pills was “their solution”, they were putting her health in greater danger with this recommendation. We went after the root causes and here are the results:
In 2002, the NIH halted a Women’s Health Initiative study that indicated that long-term estrogen/progestin hormone use posed more health risks than benefits, such as an increased chance of heart attacks, strokes, and breast cancer. (6,7)
- The rate of women having Coronary Heart Disease (CHD) was increased by 29% for women taking estrogen plus progestin.
- Stroke rates were also higher in women receiving estrogen plus progestin (41% increase).
- Women in the group treated with estrogen plus progestin had twofold greater rates of Venous Thromboembolism (VTE), as well as Deep Vein Thrombosis (DVT) and pulmonary embolism individually.
- The total rate of cardiovascular disease, including other events requiring hospitalization, was increased by 22% in the group treated with estrogen plus progestin.
- The HRT-treated group had a 26% increase in invasive breast cancer compared with the group receiving placebo.
The trial was stopped because of elevation in the breast cancer cases had reached the previously set maximum number of women allowed to develop cancer during a clinical trial. They already knew it causes cancer and had set a maximum, yet no maximum is set on the number of real women developing cancer from bcp’s in phase (post marketing) IV trials.
Learn how to catch early systemic inflammation by becoming the lab reading warrior you were meant to be. Many women out there have used synthetic hormones in the past and have never had their inflammation markers measured. Learn how to do it.
It’s Up to Us to Stop the Drug-Induced Disease Epidemic
Western medicine’s hypocrisy has led to an epidemic of drug-induced diseases. It’s time to shift the focus from profit-driven treatments to true patient healing. If we don’t take a stand now, more lives will be caught in the never-ending cycle of prescription drugs that do more harm than good. The choice is clear: honor the Hippocratic Oath, or be complicit in the hypocrisy of modern medicine.
References
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. (2007). “Combined Estrogen-Progestogen Contraceptives and Combined Estrogen-Progestogen Menopausal Therapy.” World Health Organization.
Collaborative Group on Hormonal Factors in Breast Cancer. (2019). “Type and Timing of Menopausal Hormone Therapy and Breast Cancer Risk: Individual Participant Meta-Analysis of the Worldwide Epidemiological Evidence.” The Lancet Oncology.
Bosetti, C., Bravi, F., Negri, E., et al. (2002). “Oral Contraceptives and the Risk of Liver Cancer.” Journal of the National Cancer Institute.